2018-09901. National Institute on Drug Abuse; Notice of Closed Meeting  

  • Start Preamble Start Printed Page 21301

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

    The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Rodent Testing to Identify Pharmacotherapies for Substance Dependence (8936).

    Date: May 24, 2018.

    Time: 10:00 a.m. to 12:00 p.m.

    Agenda: To review and evaluate contract proposals.

    Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call).

    Contact Person: Lyle Furr, Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892-9550, (301) 827-5702, lf33c.nih.gov.

    (Catalogue of Federal Domestic Assistance Program No.: 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS)

    Start Signature

    Dated: May 4, 2018.

    Natasha M. Copeland,

    Program Analyst, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 2018-09901 Filed 5-8-18; 8:45 am]

    BILLING CODE 4140-01-P

Document Information

Published:
05/09/2018
Department:
Health and Human Services Department
Agency:
National Institutes of Health
EntryType:
Notice
Document Number:
2018-09901
Dates:
May 24, 2018.
Pages:
21301-21301 (1 pages)
SectionNoes:
PDF File:
2018-09901.pdf